logo-loader

Summit Corporation's Pye on positive data for DMD treatment

Published: 10:09 10 Oct 2014 BST

Summit Corporation (LON:SUMM), a UK-based drug discovery and development company,  has just reported some positive results from stage 1 trials of its new treatment for Duchenne Muscular Dystrophy.

Director Dr Richard Pye tells Proactive Investors that although this is not a cure, it could help prevent muscle deterioration in this 'orphan' medical condition and prolong the life expectancy of young patients.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 26 minutes ago